An exploratory study to evaluate immune restoration after removal of viral antigen in adults with genotype 1a chronic hepatitis C virus infection treated with ombitasvir/oparitapre... von Carlton-Smith, C, Holmes, J.A, Kim, A.Y, Dumas, E.O, Brown, J, Alatrakchi, N, Lauer, G.M, Silva, S.T, Tonnerre, P, Cohen, D.E, Zhang, H, Shulman, N.S, Chung, R.T

Volltext

The effect of ribavirin dosage on the kinetics of viral load decline and drug exposures in plasma and liver with OBV/PTV/r + DSV treatment in patients with chronic hepatitis C viru... von Talal, A.H, Dumas, E.O, Bauer, B, Rejman, R.M, Ocque, A, Morse, G.D, Lucic, D, Cloherty, G.A, King, J, Zhang, H, Cohen, D.E, Shulman, N, Pawlotsky, J.-M, Hézode, C

Volltext

Safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir and ± ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3–6) von Agarwal, K, Brown, R.S, Dumas, E.O, McCaughan, G.W, Samuel, D, Terrault, N, Brown, K.A, Mantry, P.S, Berenguer, M, Kwo, P.Y, O’leary, J, Charafeddine, M, Pilot-Matias, T.J, Shuster, D.L, Lu, W, Enejosa, J.V, Cohen, D.E, Mariño, Z, Forns, X

Volltext

MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection von Reau, N, Kwo, P.Y, Rhee, S, Brown, R.S, Agarwal, K, Angus, P, Gane, E, Kao, J.-H, Mantry, P.S, Reddy, K.R, Tran, T.T, Hu, Y.B, Gulati, A, Ng, T.I, Dumas, E.O, Shulman, N, Trinh, R, Forns, X

Volltext

P1331 : Phase 3B studies to assess long-term clinical outcomes in HCV GT1-infected patients treated with ombitasvir/ paritaprevir/ritonavir and dasabuvir with or without ribavirin von Dumas, E.O, Enejosa, J, Ball, G, Hu, Y.B, Co, M, Kumar Pothacamury, R, Liu, Y, Shulman, N, Podsadecki, T

Volltext

P0781 : High SVR rates despite multiple negative predictors in genotype 1 patients receiving ombitasvir/paritaprevir/R, dasabuvir with or without ribavirin for 12 and 24 weeks: Int... von Reau, N, Fried, M.W, Wedemeyer, H, Cooper, C, Diago, M, Craxi, A, Strasser, S, Dufour, J.-F, Xie, W, Larsen, L, Dumas, E.O, Bernstein, D

Volltext

1204 PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV NS5A INHIBITOR ABT-267 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY ADULT VOLUNTEERS von Dumas, E.O, Lawal, A, Menon, R.M, Podsadecki, T, Awni, W, Dutta, S, Williams, L

Volltext

SAT-259 - An exploratory study to evaluate immune restoration after removal of viral antigen in adults with genotype 1a chronic hepatitis C virus infection treated with ombitasvir/... von Carlton-Smith, C., Holmes, J.A., Kim, A.Y., Dumas, E.O., Brown, J., Alatrakchi, N., Lauer, G.M., Silva, S.T., Tonnerre, P., Cohen, D.E., Zhang, H., Shulman, N.S., Chung, R.T.

Volltext

FRI-267 - Safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir and ± ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3–... von Agarwal, K., Brown, R.S., Dumas, E.O., McCaughan, G.W., Samuel, D., Terrault, N., Brown, K.A., Mantry, P.S., Berenguer, M., Kwo, P.Y., O’leary, J., Charafeddine, M., Pilot-Matias, T.J., Shuster, D.L., Lu, W., Enejosa, J.V., Cohen, D.E., Mariño, Z., Forns, X.

Volltext

THU-222 - The effect of ribavirin dosage on the kinetics of viral load decline and drug exposures in plasma and liver with OBV/PTV/r + DSV treatment in patients with chronic hepati... von Talal, A.H., Dumas, E.O., Bauer, B., Rejman, R.M., Ocque, A., Morse, G.D., Lucic, D., Cloherty, G.A., King, J., Zhang, H., Cohen, D.E., Shulman, N., Pawlotsky, J.-M., Hézode, C.

Volltext

LBO-03 - MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection von Reau, N., Kwo, P.Y., Rhee, S., Brown, R.S., Agarwal, K., Angus, P., Gane, E., Kao, J.-H., Mantry, P.S., Reddy, K.R., Tran, T.T., Hu, Y.B., Gulati, A., Ng, T.I., Dumas, E.O., Shulman, N., Trinh, R., Forns, X.

Volltext

How long do unilateral target zones last? von Dumas, Bernard, Svensson, Lars E.O.

Volltext

Seminar Paper / Institute for International Economic Studies, Stockholm University von Svensson Lars E.O. , Stockholms universitet, Institutet för internationell ekonomi, Dumas Bernard , Wharton School of the University of Pennsylvania

Volltext bestellen

How Long do Unilateral Target Zones Last? von Dumas, Bernard, Svensson, Lars E.O.

Volltext bestellen

How Long do Unilateral Target Zones Last? von Dumas, Bernard, Lars EO Svensson

Volltext